News

The Purdy family shares their insights on navigating their child’s rare neurodegenerative disease and their direct ...
The researchers found that women with PMDs had a higher risk for any CVD compared with those without PMDs in the population analysis and the sibling analysis (adjusted hazard ratios, 1.11 and 1.10, ...
Increased odds of dizziness, nausea, vertigo, and nervousness were seen with discontinuation of antidepressants compared with placebo discontinuation. HealthDay News — Most individuals do not go ...
HealthDay News — Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA Network Open.
Topline results were announced from a phase 3 trial evaluating atogepant vs topiramate in adults with a history of 4 or more migraine days per month.
FNP-223, previously known as ASN90, is a reversible and substrate-competitive O-GlcNAcase enzyme inhibitor. The oral investigational drug is expected to rapidly increase O-GlcNAcylated tau proteins, ...
HealthDay News — Air pollution, including ultrafine particles (UFP), may be associated with developing meningiomas, according to a study published online July 9 in Neurology.
Compared with full onsite work, high frequency and full-time remote work are negatively associated with being at risk for insomnia.
Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm.
A diagnostic model based on delayed post-gadolinium enhancement magnetic resonance imaging improves the accuracy of Meniere disease diagnosis.
HealthDay News — Early-onset neonatal sepsis and meningitis are associated with an increased risk for childhood epilepsy, according to a study published online July 7 in JAMA Network Open.
Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.